The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Abstract
Although at the genetic level cancer is caused by diverse mutations, epigenetic modifications are characteristic of all cancers, from apparently normal precursor tissue to advanced metastatic disease, and these epigenetic modifications drive tumour cell heterogeneity. We propose a unifying model of cancer in which epigenetic dysregulation allows rapid selection for tumour cell survival at the expense of the host. Mechanisms involve both genetic mutations and epigenetic modifications that disrupt the function of genes that regulate the epigenome itself. Several exciting recent discoveries also point to a genome-scale disruption of the epigenome that involves large blocks of DNA hypomethylation, mutations of epigenetic modifier genes and alterations of heterochromatin in cancer (including large organized chromatin lysine modifications (LOCKs) and lamin-associated domains (LADs)), all of which increase epigenetic and gene expression plasticity. Our model suggests a new approach to cancer diagnosis and therapy that focuses on epigenetic dysregulation and has great potential for risk detection and chemoprevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Genome-wide methylation profiles reveal quantitative views of human aging rates
Hannum, G., Guinney, J., Zhao, L., Zhang, L., Hughes, G., Sadda, S., Klotzle, B., Bibikova, M., Fan, J.-B., Gao, Y., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.016 · Cited by 4,270
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D. T. W., Pfaff, E., Jacob, K., Sturm, D., Fontebasso, A. M., Quang, D.-A. K., Tönjes, M., et al. (2012) · Nature · doi:10.1038/nature10833 · Cited by 2,631
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Feinberg, A. P., & Vogelstein, B. (1983) · Nature · doi:10.1038/301089a0 · Cited by 2,437
Self-citationCOSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Self-citationDNMT3A Mutations in Acute Myeloid Leukemia
Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983
Natural selection and random genetic drift in phenotypic evolution
Lande, R. (1976) · Evolution · doi:10.1111/j.1558-5646.1976.tb00911.x · Cited by 1,828
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2012) · Nature Genetics · doi:10.1038/ng.1102 · Cited by 1,724
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G., Antosiewicz-Bourget, J., O’Malley, R., Castanon, R., Klugman, S., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,549
Morin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Control of Stochasticity in Eukaryotic Gene Expression
Raser, J. M., & O'Shea, E. K. (2004) · Science · doi:10.1126/science.1098641 · Cited by 1,425
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
The genomic complexity of primary human prostate cancer
Berger, M. F., Lawrence, M. S., Demichelis, F., Drier, Y., Cibulskis, K., Sivachenko, A. Y., Sboner, A., Esgueva, R., Pflueger, D., Sougnez, C., et al. (2011) · Nature · doi:10.1038/nature09744 · Cited by 1,234
The Strategy of the Genes: A Discussion of Some Aspects of Theoretical Biology
(1958) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1958.tb86500.x · Cited by 1,223
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
The DNA-encoded nucleosome organization of a eukaryotic genome
Kaplan, N., Moore, I. K., Fondufe-Mittendorf, Y., Gossett, A. J., Tillo, D., Field, Y., LeProust, E. M., Hughes, T. R., Lieb, J. D., Widom, J., et al. (2009) · Nature · doi:10.1038/nature07667 · Cited by 1,194
Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.471 · Cited by 1,177
Self-citationSystematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173
Charting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P., Raine, K., Huang, D., Ong, C. K., Stephens, P., Davies, H., Jones, D., Lin, M.-L., Teague, J., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,123
Nuclear structure in cancer cells
Zink, D., Fischer, A. H., & Nickerson, J. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1430 · Cited by 1,068
Dna Hypomethylation In Cancer Cells
Ehrlich, M. (2009) · Epigenomics · doi:10.2217/epi.09.33 · Cited by 1,060
Molecular Maps of the Reorganization of Genome-Nuclear Lamina Interactions during Differentiation
Peric-Hupkes, D., Meuleman, W., Pagie, L., Bruggeman, S. W. M., Solovei, I., Brugman, W., Gräf, S., Flicek, P., Kerkhoven, R. M., van Lohuizen, M., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.016 · Cited by 1,050
Increased methylation variation in epigenetic domains across cancer types
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.865 · Cited by 1,045
Self-citationDiverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., et al. (2010) · Nature · doi:10.1038/nature09208 · Cited by 1,027
Analysis of the coding genome of diffuse large B-cell lymphoma
Pasqualucci, L., Trifonov, V., Fabbri, G., Ma, J., Rossi, D., Chiarenza, A., Wells, V. A., Grunn, A., Messina, M., Elliot, O., et al. (2011) · Nature Genetics · doi:10.1038/ng.892 · Cited by 971
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949
Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution
Booth, M. J., Branco, M. R., Ficz, G., Oxley, D., Krueger, F., Reik, W., & Balasubramanian, S. (2012) · Science · doi:10.1126/science.1220671 · Cited by 928
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Bernt, K. M., Zhu, N., Sinha, A. U., Vempati, S., Faber, J., Krivtsov, A. V., Feng, Z., Punt, N., Daigle, A., Bullinger, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.010 · Cited by 870
Induced Pluripotent Stem Cells: Past, Present, and Future
Yamanaka, S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.005 · Cited by 843
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Goelz, S. E., Vogelstein, B., Hamilton, S. R., & Feinberg, A. P. (1985) · Science · doi:10.1126/science.2579435 · Cited by 840
Self-citationLee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
Yan, X.-J., Xu, J., Gu, Z.-H., Pan, C.-M., Lu, G., Shen, Y., Shi, J.-Y., Zhu, Y.-M., Tang, L., Zhang, X.-W., et al. (2011) · Nature Genetics · doi:10.1038/ng.788 · Cited by 813
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells
Hawkins, R. D., Hon, G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.018 · Cited by 806
Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA
Yu, W., Gius, D., Onyango, P., Muldoon-Jacobs, K., Karp, J., Feinberg, A. P., & Cui, H. (2008) · Nature · doi:10.1038/nature06468 · Cited by 801
Self-citationLoss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
Lian, C. G., Xu, Y., Ceol, C., Wu, F., Larson, A., Dresser, K., Xu, W., Tan, L., Hu, Y., Zhan, Q., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.033 · Cited by 789
Transcriptional repression mediated by repositioning of genes to the nuclear lamina
Reddy, K. L., Zullo, J. M., Bertolino, E., & Singh, H. (2008) · Nature · doi:10.1038/nature06727 · Cited by 786
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells
Knutson, S. K., Wigle, T. J., Warholic, N. M., Sneeringer, C. J., Allain, C. J., Klaus, C. R., Sacks, J. D., Raimondi, A., Majer, C. R., Song, J., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1084 · Cited by 776
Isolation of a transforming sequence from a human bladder carcinoma cell line
Shih, C., & Weinberg, R. A. (1982) · Cell · doi:10.1016/0092-8674(82)90100-3 · Cited by 765
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Pugh, T. J., Weeraratne, S. D., Archer, T. C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M. O., Carter, S. L., Cibulskis, K., Erlich, R. L., et al. (2012) · Nature · doi:10.1038/nature11329 · Cited by 750
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., & Feinberg, A. P. (2003) · Science · doi:10.1126/science.1080902 · Cited by 735
Self-citationThe Genetic Landscape of the Childhood Cancer Medulloblastoma
Parsons, D. W., Li, M., Zhang, X., Jones, S., Leary, R. J., Lin, J. C.-H., Boca, S. M., Carter, H., Samayoa, J., Bettegowda, C., et al. (2011) · Science · doi:10.1126/science.1198056 · Cited by 717
A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA
Bird, A., Taggart, M., Frommer, M., Miller, O. J., & Macleod, D. (1985) · Cell · doi:10.1016/0092-8674(85)90312-5 · Cited by 712
Epigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Relationship between nucleosome positioning and DNA methylation
Chodavarapu, R. K., Feng, S., Bernatavichute, Y. V., Chen, P.-Y., Stroud, H., Yu, Y., Hetzel, J. A., Kuo, F., Kim, J., Cokus, S. J., et al. (2010) · Nature · doi:10.1038/nature09147 · Cited by 696
Acquired mutations in TET2 are common in myelodysplastic syndromes
Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 680
Berman, B. P., Weisenberger, D. J., Aman, J. F., Hinoue, T., Ramjan, Z., Liu, Y., Noushmehr, H., Lange, C. P. E., van Dijk, C. M., Tollenaar, R. A. E. M., et al. (2012) · Nature Genetics · doi:10.1038/ng.969 · Cited by 660
Chromatin organization is a major influence on regional mutation rates in human cancer cells
Schuster-Böckler, B., & Lehner, B. (2012) · Nature · doi:10.1038/nature11273 · Cited by 657 · cited 2×
“ARID1B Breast adenocarcinoma Common 5% (100) Mutation 170”
BackgroundCREBBP mutations in relapsed acute lymphoblastic leukaemia
Mullighan, C. G., Zhang, J., Kasper, L. H., Lerach, S., Payne-Turner, D., Phillips, L. A., Heatley, S. L., Holmfeldt, L., Collins-Underwood, J. R., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09727 · Cited by 637
Wen, B., Wu, H., Shinkai, Y., Irizarry, R. A., & Feinberg, A. P. (2009) · Nature Genetics · doi:10.1038/ng.297 · Cited by 614
Self-citationThe SWI/SNF complex — chromatin and cancer
Roberts, C. W. M., & Orkin, S. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1273 · Cited by 603
Hon, G. C., Hawkins, R. D., Caballero, O. L., Lo, C., Lister, R., Pelizzola, M., Valsesia, A., Ye, Z., Kuan, S., Edsall, L. E., et al. (2012) · Genome Research · doi:10.1101/gr.125872.111 · Cited by 583
Wilson, A. J., Byun, D.-S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., Arango, D., Velcich, A., Augenlicht, L. H., & Mariadason, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510023200 · Cited by 575
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma
Greger, V., Passarge, E., H�pping, W., Messmer, E., & Horsthemke, B. (1989) · Human Genetics · doi:10.1007/bf00286709 · Cited by 574
The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.-P., & Göttlicher, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00114-x · Cited by 525
Feinberg, A. P., & Irizarry, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906183107 · Cited by 522
Self-citationHypomethylation of ras oncogenes in primary human cancers
Feinberg, A. P., & Vogelstein, B. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(83)80115-6 · Cited by 514
Self-citationGenome-scale profiling of histone H3.3 replacement patterns
Mito, Y., Henikoff, J. G., & Henikoff, S. (2005) · Nature Genetics · doi:10.1038/ng1637 · Cited by 509
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004) · The Prostate · doi:10.1002/pros.20022 · Cited by 509
DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
Lofton-Day, C., Model, F., DeVos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.095992 · Cited by 493
Reduced genomic 5-methylcytosine content in human colonic neoplasia.
Feinberg, A. P., Gehrke, C. W., Kuo, K. C., & Ehrlich, M. (1988) · PubMed · Cited by 484
Self-citationExploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays
Iacobuzio-Donahue, C. A., Maitra, A., Olsen, M., Lowe, A. W., Van Heek, N. T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63911-9 · Cited by 473
Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene.
Sakai, T., Toguchida, J., Ohtani, N., Yandell, D. W., Rapaport, J. M., & Dryja, T. P. (1991) · PubMed · Cited by 466
Asymmetrically Modified Nucleosomes
Voigt, P., LeRoy, G., Drury, W. J., Zee, B. M., Son, J., Beck, D. B., Young, N. L., Garcia, B. A., & Reinberg, D. (2012) · Cell · doi:10.1016/j.cell.2012.09.002 · Cited by 460
Timescales of Genetic and Epigenetic Inheritance
Rando, O. J., & Verstrepen, K. J. (2007) · Cell · doi:10.1016/j.cell.2007.01.023 · Cited by 459
DNA Sequence-Dependent Compartmentalization and Silencing of Chromatin at the Nuclear Lamina
Zullo, J. M., Demarco, I. A., Piqué-Regi, R., Gaffney, D. J., Epstein, C. B., Spooner, C. J., Luperchio, T. R., Bernstein, B. E., Pritchard, J. K., Reddy, K. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.035 · Cited by 448
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
Warren, J. D., Xiong, W., Bunker, A. M., Vaughn, C. P., Furtado, L. V., Roberts, W. L., Fang, J. C., Samowitz, W. S., & Heichman, K. A. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-133 · Cited by 438
Jin, S.-G., Kadam, S., & Pfeifer, G. P. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq223 · Cited by 437
Comprehensive high-throughput arrays for relative methylation (CHARM)
Irizarry, R. A., Ladd-Acosta, C., Carvalho, B., Wu, H., Brandenburg, S. A., Jeddeloh, J. A., Wen, B., & Feinberg, A. P. (2008) · Genome Research · doi:10.1101/gr.7301508 · Cited by 433
Self-citationTefferi, A., Pardanani, A., Lim, K.-H., Abdel-Wahab, O., Lasho, T. L., Patel, J., Gangat, N., Finke, C. M., Schwager, S., Mullally, A., et al. (2009) · Leukemia · doi:10.1038/leu.2009.47 · Cited by 425
Inheritance of a Cancer-Associated MLH1 Germ-Line Epimutation
Hitchins, M. P., Wong, J. J. L., Suthers, G., Suter, C. M., Martin, D. I. K., Hawkins, N. J., & Ward, R. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064522 · Cited by 418
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418
Chromatin remodeling and cancer, part I: covalent histone modifications
Wang, G. G., Allis, C. D., & Chi, P. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.003 · Cited by 418
Northcott, P. A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.336 · Cited by 412
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition
McDonald, O. G., Wu, H., Timp, W., Doi, A., & Feinberg, A. P. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2084 · Cited by 379
Self-citationCis-acting noncoding RNAs: friends and foes
Guil, S., & Esteller, M. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2428 · Cited by 372
OPERating ON Chromatin, a Colorful Language where Context Matters
Gardner, K. E., Allis, C. D., & Strahl, B. D. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.01.040 · Cited by 361
The nuclear envelope environment and its cancer connections
Chow, K.-H., Factor, R. E., & Ullman, K. S. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3219 · Cited by 359
Fiskus, W., Wang, Y., Sreekumar, A., Buckley, K. M., Shi, H., Jillella, A., Ustun, C., Rao, R., Fernandez, P., Chen, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-213496 · Cited by 356
Expression Profile of Histone Deacetylase 1 in Gastric Cancer Tissues
Choi, J., Kwon, H. J., Yoon, B., Kim, J., Han, S. U., Joo, H. J., & Kim, D. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb02153.x · Cited by 346
Sensitive digital quantification of DNA methylation in clinical samples
Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341
Expression profile of class I histone deacetylases in human cancer tissues
Nakagawa, M., Oda, Y., Eguchi, T., Aishima, S.-I., Yao, T., Hosoi, F., Basaki, Y., Ono, M., Kuwano, M., Tanaka, M., et al. (2007) · Oncology Reports · doi:10.3892/or.18.4.769 · Cited by 341
Epigenetic changes in colorectal cancer
Kondo, Y., & Issa, J.-P. J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025806911782 · Cited by 338
Huang, B. H., Laban, M., Leung, C. H.-W., Lee, L., Lee, C. K., Salto-Tellez, M., Raju, G. C., & Hooi, S. C. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401567 · Cited by 337
Loss of Imprinting of Igf2 Alters Intestinal Maturation and Tumorigenesis in Mice
Sakatani, T., Kaneda, A., Iacobuzio-Donahue, C. A., Carter, M. G., de Boom Witzel, S., Okano, H., Ko, M. S. H., Ohlsson, R., Longo, D. L., & Feinberg, A. P. (2005) · Science · doi:10.1126/science.1108080 · Cited by 321
Self-citationHigh Throughput Characterization of Combinatorial Histone Codes
Young, N. L., DiMaggio, P. A., Plazas-Mayorca, M. D., Baliban, R. C., Floudas, C. A., & Garcia, B. A. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900238-mcp200 · Cited by 312
Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.
Sato, N., Maitra, A., Fukushima, N., van Heek, N. T., Matsubayashi, H., Iacobuzio–Donahue, C. A., Rosty, C., & Goggins, M. (2003) · PubMed · Cited by 304
HDAC6 Expression Is Correlated with Better Survival in Breast Cancer
Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y., Mita, K., Hamaguchi, M., Hayashi, S.-I., & Iwase, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0455 · Cited by 293
Differential expression of selected histone modifier genes in human solid cancers
Özdağ, H., Teschendorff, A. E., Ahmed, A. A., Hyland, S. J., Blenkiron, C., Bobrow, L., Veerakumarasivam, A., Burtt, G., Subkhankulova, T., Arends, M. J., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-90 · Cited by 259
Saito, Y., Kanai, Y., Nakagawa, T., Sakamoto, M., Saito, H., Ishii, H., & Hirohashi, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11127 · Cited by 259
Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling
Wang, G. G., Allis, C. D., & Chi, P. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.004 · Cited by 254
DNA secondary structures and epigenetic determinants of cancer genome evolution
De, S., & Michor, F. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2089 · Cited by 252
Cancer genetics of epigenetic genes
Miremadi, A., Oestergaard, M. Z., Pharoah, P. D. P., & Caldas, C. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm021 · Cited by 249
Altered sirtuin expression is associated with node-positive breast cancer
Ashraf, N., Zino, S., MacIntyre, A., Kingsmore, D., Payne, A. P., George, W. D., & Shiels, P. G. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603384 · Cited by 248
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
Kosmider, O., Gelsi-Boyer, V., Ciudad, M., Racoeur, C., Jooste, V., Vey, N., Quesnel, B., Fenaux, P., Bastie, J.-N., Beyne-Rauzy, O., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.011205 · Cited by 247
De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.
Jones, P. A., Wolkowicz, M. J., Rideout, W. M., Gonzales, F. A., Marziasz, C. M., Coetzee, G. A., & Tapscott, S. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6117 · Cited by 234
Lu, P. J., Sundquist, K., Baeckstrom, D., Poulsom, R., Hanby, A., Meier-Ewert, S., Jones, T., Mitchell, M., Pitha-Rowe, P., Freemont, P., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15633 · Cited by 230
Kawai, H., Li, H., Avraham, S., Jiang, S., & Avraham, H. K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11403 · Cited by 226
High order chromatin architecture shapes the landscape of chromosomal alterations in cancer
Fudenberg, G., Getz, G., Meyerson, M., & Mirny, L. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.2049 · Cited by 207
Nestor, C., Ruzov, A., Meehan, R. R., & Dunican, D. S. (2010) · BioTechniques · doi:10.2144/000113403 · Cited by 206
Badal, V., Chuang, L. S. H., Tan, E. H.-H., Badal, S., Villa, L. L., Wheeler, C. M., Li, B. F. L., & Bernard, H.-U. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6227-6234.2003 · Cited by 200
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
Popovici-Muller, J., Saunders, J. O., Salituro, F. G., Travins, J. M., Yan, S., Zhao, F., Gross, S., Dang, L., Yen, K. E., Yang, H., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300225h · Cited by 200
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
Sproul, D., Kitchen, R. R., Nestor, C. E., Dixon, J. M., Sims, A. H., Harrison, D. J., Ramsahoye, B. H., & Meehan, R. R. (2012) · Genome Biology · doi:10.1186/gb-2012-13-10-r84 · Cited by 191
Aging, DNA methylation and cancer
Issa, J.-P. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00019-0 · Cited by 185
Teschendorff, A. E., Jones, A., Fiegl, H., Sargent, A., Zhuang, J. J., Kitchener, H. C., & Widschwendter, M. (2012) · Genome Medicine · doi:10.1186/gm323 · Cited by 182
High-Resolution Enzymatic Mapping of Genomic 5-Hydroxymethylcytosine in Mouse Embryonic Stem Cells
Sun, Z., Terragni, J., Borgaro, J. G., Liu, Y., Yu, L., Guan, S., Wang, H., Sun, D., Cheng, X., Zhu, Z., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.001 · Cited by 172
Estève, P.-O., Chin, H. G., & Pradhan, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407729102 · Cited by 165
Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer
Jung-Hynes, B., Nihal, M., Zhong, W., & Ahmad, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807869200 · Cited by 165
Sproul, D., Nestor, C., Culley, J., Dickson, J. H., Dixon, J. M., Harrison, D. J., Meehan, R. R., Sims, A. H., & Ramsahoye, B. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013224108 · Cited by 159
Peng, D., Kanai, Y., Sawada, M., Ushijima, S., Hiraoka, N., Kitazawa, S., & Hirohashi, S. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi361 · Cited by 159
Cooper, D. N., Mort, M. E., Stenson, P. D., Ball, E. V., & Chuzhanova, N. A. (2010) · Human Genomics · doi:10.1186/1479-7364-4-6-406 · Cited by 155
Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers
Kanai, Y., Ushijima, S., Nakanishi, Y., Sakamoto, M., & Hirohashi, S. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00689-4 · Cited by 149
Identification of Somatic Mutations in Parathyroid Tumors Using Whole-Exome Sequencing
Cromer, M. K., Starker, L. F., Choi, M., Udelsman, R., Nelson-Williams, C. J., Lifton, R. P., & Carling, T. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1743 · Cited by 148
McCarthy, H. O., Wierda, W. G., Barron, L. L., Cromwell, C. C., Wang, J., Coombes, K. R., Rangel, R., Elenitoba‐Johnson, K. S. J., Keating, M. J., & Abruzzo, L. V. (2003) · Blood · doi:10.1182/blood-2002-09-2906 · Cited by 148
EZH2 Y641 mutations in follicular lymphoma
Bödör, C., Ó’Riain, C., Wrench, D., Matthews, J., Iyengar, S., Tayyib, H., Calaminici, M., Clear, A. J., Iqbal, S., Quentmeier, H., et al. (2011) · Leukemia · doi:10.1038/leu.2010.311 · Cited by 147
Studies of X chromosome DNA methylation in normal human cells
Wolf, S. F., & Migeon, B. R. (1982) · Nature · doi:10.1038/295667a0 · Cited by 147
Histone H2A.Z cooperates with RNAi and heterochromatin factors to suppress antisense RNAs
Zofall, M., Fischer, T., Zhang, K., Zhou, M., Cui, B., Veenstra, T. D., & Grewal, S. I. S. (2009) · Nature · doi:10.1038/nature08321 · Cited by 145
Alvarez, H., Opalinska, J., Zhou, L., Sohal, D. P. S., Fazzari, M. J., Yu, Y., Montagna, C., Montgomery, E. A., Canto, M. I., Dunbar, K. B., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001356 · Cited by 142
Loss of Imprinting ofIGF2: A Common Epigenetic Modifier of Intestinal Tumor Risk
Kaneda, A., & Feinberg, A. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2959 · Cited by 135
Self-citationIncreased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer
Agoston, A. T., Argani, P., Yegnasubramanian, S., Marzo, A. M. D., Ansari-Lari, M. A., Hicks, J. L., Davidson, N. E., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501675200 · Cited by 135
Chen, M.-L., Shen, F., Huang, W., Qi, J., Wang, Y., Feng, Y., Liu, S.-M., & Yuan, B. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.193938 · Cited by 135
Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening
Zou, H., Harrington, J. J., Shire, A. M., Rego, R. L., Wang, L., Campbell, M. E., Oberg, A. L., & Ahlquist, D. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0518 · Cited by 131
O6-Methylguanine-DNA methyltransferase in glioma therapy: Promise and problems
Silber, J. R., Bobola, M. S., Blank, A., & Chamberlain, M. C. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.12.004 · Cited by 125
Zhuang, J. J., Jones, A., Lee, S., Ng, E., Fiegl, H., Zikán, M., Cibula, D., Sargent, A., Salvesen, H. B., Jacobs, I. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002517 · Cited by 121
Teschendorff, A. E., & Widschwendter, M. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts170 · Cited by 118
Mutations and Deletions of the CBP Gene in Human Lung Cancer
Kishimoto, M., Kohno, T., Okudela, K., Otsuka, A., Sasaki, H., Tanabe, C., Sakiyama, T., Hirama, C., Kitabayashi, I., Minna, J. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.512.11.2 · Cited by 117
Akiyama, Y., Maesawa, C., Ogasawara, S., Terashima, M., & Masuda, T. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63549-3 · Cited by 114
BRCA2 associates with acetyltransferase activity when bound to P/CAF
Fuks, F., Milner, J., & Kouzarides, T. (1998) · Oncogene · doi:10.1038/sj.onc.1202475 · Cited by 113
Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment
Lin, Z., Bazzaro, M., Wang, M., Chan, K. C. G., Peng, S., & Roden, R. B. S. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1813 · Cited by 111
Butcher, D. T., & Rodenhiser, D. I. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.09.002 · Cited by 110
Promoter methylation of cyclin D2 gene in gastric carcinoma
Oshimo, Y., Nakayama, H., Ito, R., Kitadai, Y., Yoshida, K., Chayama, K., & Yasui, W. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.6.1663 · Cited by 109
Kaneda, A., Wang, C. J., Cheong, R., Timp, W., Onyango, P. O., Wen, B., Iacobuzio–Donahue, C. A., OHLSSON, R. I., Andraos, R., Pearson, M. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710359105 · Cited by 102
Self-citationNakamura, N., & Takenaga, K. (1998) · Clinical & Experimental Metastasis · doi:10.1023/a:1006589626307 · Cited by 100
Common fragile sites are characterized by histone hypoacetylation
Jiang, Y., Lucas, I., Young, D. J., Davis, E. M., Karrison, T. G., Rest, J. S., & Beau, M. M. L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp410 · Cited by 99
The role of nuclear organization in cancer
Lever, E., & Sheer, D. (2009) · The Journal of Pathology · doi:10.1002/path.2651 · Cited by 95
Sun, L., Zhao, H., Xu, Z., et al. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.06.014 · Cited by 90
Woodson, K. G., Flood, A. P., Green, L. D., Tangrea, J. A., Hanson, J., Cash, B. D., Schatzkin, A. G., & Schoenfeld, P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh042 · Cited by 78
Nakagawa, T., Kanai, Y., Ushijima, S., Kitamura, T., Kakizoe, T., & Hirohashi, S. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000154632.11824.4d · Cited by 75
Cho, M., Uemura, H., Kim, S., Kawada, Y., Yoshida, K., Hirao, Y., Konishi, N., Saga, S., & Yoshikawa, K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1951 · Cited by 67
Pittella-Silva, F., Hamamoto, R., Kunizaki, M., Tsuge, M., Nakamura, Y., & Furukawa, Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210929 · Cited by 64
Shah, M. Y., Vasanthakumar, A., Barnes, N. Y., Figueroa, M. E., Kamp, A., Hendrick, C., Ostler, K. R., Davis, E. M., Lin, S., Anastasi, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0847 · Cited by 63
The BRCA2 is a histone acetyltransferase
Siddique, H., Zou, J.-P., Rao, V. N., & Reddy, E. S. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202003 · Cited by 63
Unanswered Questions about the Role of Promoter Methylation in Carcinogenesis
Bestor, T. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05959.x · Cited by 53
Wen, B., Wu, H., Loh, Y., Briem, E., Daley, G. Q., & Feinberg, A. P. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-566 · Cited by 51
Self-citationHuman DNA methyltransferase gene DNMT1 is regulated by the APC pathway
Campbell, P. M. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.17 · Cited by 49
Erasure of MLH1 methylation in spermatozoa—implications for epigenetic inheritance
Hitchins, M. P., & Ward, R. L. (2007) · Nature Genetics · doi:10.1038/ng1107-1289 · Cited by 49
Gene expression anti-profiles as a basis for accurate universal cancer signatures
Bravo, H. C., Pihur, V., McCall, M. N., Irizarry, R. A., & Leek, J. T. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-272 · Cited by 48
de Capoa, A., Musolino, A., Rosa, S. D., Caiafa, P., Mariani, L., Nonno, F. D., Vocaturo, A., Donnorso, R. P., Niveleau, A., & Grappelli, C. (2003) · PubMed · Cited by 44
Levanon, D., Bernstein, Y., Negreanu, V., Bone, K. R., Pozner, A., Eilam, R., Lotem, J., Brenner, O. J., & Groner, Y. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100168 · Cited by 43
Hosoya, K., Yamashita, S., Ando, T., Nakajima, T., Itoh, F., & Ushijima, T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.016 · Cited by 43
COX-2 Active Agents in the Chemoprevention of Colorectal Cancer
Kraus, S. R., Naumov, I., & Arber, N. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-30331-9_5 · Cited by 36
CBP truncating mutations in ovarian cancer
Ward, R. C., Johnson, M., Shridhar, V., van Deursen, J., & Couch, F. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.025080 · Cited by 34
A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction
Timp, W., Levchenko, A., & Feinberg, A. P. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7542 · Cited by 32
Self-citationLiang-tao, Z., Zhang, L., Zhang, J., Ye, X., Xie, A.-M., Chen, L., Kang, J. X., & Cai, C. (2013) · Bioanalysis · doi:10.4155/bio.13.28 · Cited by 29
A Point‐by‐Point Response to Recent Arguments Against the Use of Statins in Primary Prevention
Joshi, P. H., Chaudhari, S., Blaha, M. J., Jones, S. R., Martin, S. S., Post, W. S., Cannon, C. P., Fonarow, G. C., Wong, N. D., Amsterdam, E. A., et al. (2012) · Clinical Cardiology · doi:10.1002/clc.22016 · Cited by 13
Large chromatin domains in pluripotent and differentiated cells
Hu, S., Cheng, L., & Wen, B. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr108 · Cited by 8
Cited by
Epigenetic plasticity and the hallmarks of cancer
Flavahan, W. A., Gaskell, E., & Bernstein, B. E. (2017) · Science · doi:10.1126/science.aal2380 · Cited by 1,340
“However, pervasive alterations in chromatin state, methylation, and gene expression suggest that the contributions of epigenetic alterations must also be carefully considered (3, 92).”
BackgroundEpigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
Peng, D., Kryczek, I., Nagarsheth, N., Zhao, L., Wei, S., Wang, W., Sun, Y., Zhao, E., Vatan, L., Szeliga, W., et al. (2015) · Nature · doi:10.1038/nature15520 · Cited by 1,201
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Feinberg, A. P., Koldobskiy, M. A., & Göndör, A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.13 · Cited by 841
Self-citationThe Key Role of Epigenetics in Human Disease Prevention and Mitigation
Feinberg, A. P. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1402513 · Cited by 638
Self-citation
Metadata
- Authors
- Timp, W., & Feinberg, A. P.
- Venue
- Nature Reviews Cancer
- Published
- 2013-06-13
- Volume
- 13
- Issue
- 7
- Pages
- 497-510
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1990711772
- Cited by
- 586
- References
- 191
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.